These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19090919)

  • 1. LigEvolutioner, a new strategy for modification and optimization of lead compounds in receptor/ligand complexes.
    Zhou P; Tian F; Shang Z
    Chem Biol Drug Des; 2008 Dec; 72(6):525-32. PubMed ID: 19090919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization.
    Grosdidier A; Zoete V; Michielin O
    Proteins; 2007 Jun; 67(4):1010-25. PubMed ID: 17380512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential.
    Liu Z; Dominy BN; Shakhnovich EI
    J Am Chem Soc; 2004 Jul; 126(27):8515-28. PubMed ID: 15238009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general approach for developing system-specific functions to score protein-ligand docked complexes using support vector inductive logic programming.
    Amini A; Shrimpton PJ; Muggleton SH; Sternberg MJ
    Proteins; 2007 Dec; 69(4):823-31. PubMed ID: 17910057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DynaDock: A new molecular dynamics-based algorithm for protein-peptide docking including receptor flexibility.
    Antes I
    Proteins; 2010 Apr; 78(5):1084-104. PubMed ID: 20017216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Information theory-based scoring function for the structure-based prediction of protein-ligand binding affinity.
    Kulharia M; Goody RS; Jackson RM
    J Chem Inf Model; 2008 Oct; 48(10):1990-8. PubMed ID: 18767831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational tools for the analysis and visualization of multiple protein-ligand complexes.
    O'Brien SE; Brown DG; Mills JE; Phillips C; Morris G
    J Mol Graph Model; 2005 Dec; 24(3):186-94. PubMed ID: 16169759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
    Popov VM; Yee WA; Anderson AC
    Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural prediction of peptides bound to MHC class I.
    Fagerberg T; Cerottini JC; Michielin O
    J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CORES: an automated method for generating three-dimensional models of protein/ligand complexes.
    Hare BJ; Walters WP; Caron PR; Bemis GW
    J Med Chem; 2004 Sep; 47(19):4731-40. PubMed ID: 15341488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
    Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
    Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities.
    Jayalakshmi V; Rama Krishna N
    J Magn Reson; 2004 May; 168(1):36-45. PubMed ID: 15082247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From modeling to medicinal chemistry: automatic generation of two-dimensional complex diagrams.
    Stierand K; Rarey M
    ChemMedChem; 2007 Jun; 2(6):853-60. PubMed ID: 17436259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput X-ray crystallography for drug discovery.
    Blundell TL; Patel S
    Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and optimization of structure-based virtual screening protocols. (3). New methods and old problems in scoring function design.
    Smith R; Hubbard RE; Gschwend DA; Leach AR; Good AC
    J Mol Graph Model; 2003 Sep; 22(1):41-53. PubMed ID: 12798390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New method for fast and accurate binding-site identification and analysis.
    Halgren T
    Chem Biol Drug Des; 2007 Feb; 69(2):146-8. PubMed ID: 17381729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.